A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions

Clamp Study

Interventions

DRUG

Insulin Aspart

insulin aspart in doses 0.3 IU/kg

DRUG

NovoRapid® Penfill®

insulin aspart in doses 0.3 IU/kg

Trial Locations (2)

Endocrinology Research Centre, Moscow

Almazov National Medical Research Centre, Saint Petersburg